Clinical Trial Update: Effects of Oral Doxofylline and Procaterol on Chronic Obstructive Pulmonary Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial exploring effects of oral doxofylline and procaterol on chronic obstructive pulmonary disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Doxofylline (doxofylline)
• Procaterol (procaterol)

Snippet

Sponsor: Thammasat University | Conditions: COPD | Phase 4 | Status: COMPLETED